R. Daniel Beauchamp

Colleagues, trainees and family members attended the recent Beauchamp Research Day. Left to right are invited lecturer Jen Jen Yeh, MD, Beauchamp’s wife Shannon, daughter Bryn, James Goldenring, MD, PhD, Paul W. Sanger Professor of Experimental Surgery and vice chair for Surgical Research, and Seth Karp, MD, H. William Scott Jr. Professor of Surgery and chair of the Section of Surgical Sciences. (photo by Khristina Prince)

R. Daniel Beauchamp’s legacy shines at research symposium spotlighting investigations

Beauchamp Research Day honors his legacy and celebrates the achievements of others he inspired, collaborated with or advised.

From left, Mark Evers, MD; Seth Carp, MD; Robert Coffey, MD; Carmen Solórzano, MD; J. Joshua Smith, MD, PhD; Naji N. Abumrad, MD; Steven Leach, MD; and Paula Marincola Smith, MD, PhD, pose for a photo during the R. Daniel Beauchamp Memorial Symposium at Vanderbilt University Medical Center. Not pictured, David Hanna, MD. (hoto by Erin O. Smith)

Beauchamp honored at symposium highlighting basic research by surgeon scientists

The profound impact of R. Daniel Beauchamp, MD, former chair of the Section of Surgical Sciences at Vanderbilt University Medical Center, was deeply evident at a recent symposium highlighting basic research conducted by numerous surgeons and physician-scientists, all of whom were closely associated with the noted physician-scientist.

Section of Surgical Sciences professional biography for R. Daniel Beauchamp, MD

Section of Surgical Sciences professional biography for R. Daniel Beauchamp, MD

Anna Means, PhD, R. Daniel Beauchamp, MD, and colleagues are studying a group of proteins that are essential to the growth of colorectal cancer tumors.

Researchers find potential new target against colorectal cancer

Protein’s role in inflammation-related cancer studied

Investigators are exploring the molecular mechanisms behind the association of chronic inflammation and colon cancer.

SMAD4 clue to colon cancer

Loss of a gene that is part of the TGF-beta signaling pathway increased inflammation in the colon and was observed in half of human colitis-associated cancers.

1 2